| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.8M | +3.3% |
| Cost of Revenue | $4.7M | +3.2% |
| Gross Profit | $4.1M | +3.5% |
| R&D Expense | $2.8M | +13.2% |
| SG&A Expense | $4.2M | +251.9% |
| Operating Income | -$6.1M | -228.0% |
| Interest Expense | $830K | +20.3% |
| Net Income | -$11.0M | -109.1% |
| EPS (Basic) | -$0.95 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.9M | +469.0% |
| Short-term Investments | $1.6M | — |
| Accounts Receivable | $3.0M | +41.3% |
| Inventory | $1.2M | +31.4% |
| Current Assets | $10.9M | +163.8% |
| Total Assets | $14.8M | +216.4% |
| Current Liabilities | $6.2M | +4.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.8M | -185.0% |
| Capital Expenditures | $54K | +0.0% |
| Investing Cash Flow | -$4.0M | -7370.4% |
| Financing Cash Flow | $15.3M | +426.4% |
| Free Cash Flow | -$7.8M | -181.4% |
| +62.9% |
| EPS (Diluted) | -$0.95 | +62.9% |
| Total Liabilities |
| $11.6M |
| -38.2% |
| Stockholders' Equity | $3.3M | +116.7% |